UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

The Journal of urology, 2018-03, Vol.199 (3), p.683-690

2018

Volltextzugriff (PDF)

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

The Journal of urology, 2018-04, Vol.199 (4), p.990-997

2018

Volltextzugriff (PDF)

Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation

Proceedings of the National Academy of Sciences - PNAS, 2014-07, Vol.111 (27), p.9887-9892

2014

Volltextzugriff (PDF)

The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

The Journal of urology, 2015-04, Vol.193 (4), p.1163-1169

2015

Volltextzugriff (PDF)

Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form

Urology (Ridgewood, N.J.), 2015, Vol.85 (1), p.101-106

2015

Volltextzugriff (PDF)

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

Journal of clinical oncology, 2014-12, Vol.32 (36), p.4066-4072

2014

Volltextzugriff (PDF)

The role of active vaccination in cancer immunotherapy: lessons from clinical trials

Current opinion in immunology, 2015-08, Vol.35, p.15-22

2015

Volltextzugriff (PDF)

Prediction of erectile function following treatment for prostate cancer

JAMA : the journal of the American Medical Association, 2011-09, Vol.306 (11), p.1205

2011

Volltextzugriff (PDF)

Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials

JNCI : Journal of the National Cancer Institute, 2014-07, Vol.106 (7), p.1

2014

Volltextzugriff (PDF)

High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells

Nature communications, 2022-06, Vol.13 (1), p.3385-3385, Article 3385

2022

Volltextzugriff (PDF)

The polycomb group protein EZH2 is involved in progression of prostate cancer

Nature (London), 2002-10, Vol.419 (6907), p.624-629

2002

Volltextzugriff (PDF)

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

Urologic oncology, 2013-07, Vol.31 (5), p.566-571

2013

Volltextzugriff (PDF)

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Clinical cancer research, 2009-09, Vol.15 (18), p.5794-5802

2009

Volltextzugriff (PDF)

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

Cancer, 2014-04, Vol.120 (7), p.1076-1082

2014

Volltextzugriff (PDF)

Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy

Radiotherapy and oncology, 2015-08, Vol.116 (2), p.179-184

2015

Volltextzugriff (PDF)

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

Clinical cancer research, 2009-07, Vol.15 (14), p.4706-4711

2009

Volltextzugriff (PDF)

Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2772-2780

2005

Volltextzugriff (PDF)

Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer

Cancer, 2013-05, Vol.119 (9), p.1729-1735

2013

Volltextzugriff (PDF)

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Nature (London), 2019-12, Vol.576 (7787), p.465-470

2019

Volltextzugriff (PDF)

Living With Prostate Cancer: Patients' and Spouses' Psychosocial Status and Quality of Life

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4171-4177

2007

Volltextzugriff (PDF)

Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort

Journal of clinical oncology, 2009-10, Vol.27 (30), p.4980-4985

2009

Volltextzugriff (PDF)

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide

PloS one, 2010-06, Vol.5 (6), p.e11311-e11311

2010

Volltextzugriff (PDF)

Linear biomarker combination for constrained classification

The Annals of statistics, 2022-10, Vol.50 (5), p.2793-2815

2022

Volltextzugriff (PDF)

Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration

The Journal of urology, 2013-05, Vol.189 (5), p.1702-1706

2013

Volltextzugriff (PDF)

[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study

The Journal of urology, 2008-08, Vol.180 (2), p.539-543

2008

Volltextzugriff (PDF)

1 – 25 von 367

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(357)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Englisch
(366)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(108)
Urology
(46)
Journal Of Clinical Oncology
(23)
The journal Of Urology/the journal Of Urology
(20)
The Prostate
(12)
Journal Of Urology
(11)
Cancer
(10)
Cancer Research
(8)
Urologic Oncology
(8)
Jnci : Journal Of The National Cancer Institute
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation

The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form

Can urinary PCA3 supplement PSA in the early detection of prostate cancer?

The role of active vaccination in cancer immunotherapy: lessons from clinical trials

Prediction of erectile function following treatment for prostate cancer

Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials

High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells

The polycomb group protein EZH2 is involved in progression of prostate cancer

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer

Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer

Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy

Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States

Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy

Patient‐reported outcomes after 3‐dimensional conformal, intensity‐modulated, or proton beam radiotherapy for localized prostate cancer

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Living With Prostate Cancer: Patients' and Spouses' Psychosocial Status and Quality of Life

Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide

Linear biomarker combination for constrained classification

Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration

[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study

Suchergebnisse filtern